Permax and pleural effusion Patient Reports February 12, 2012

Permax Side Effects Report #5636054-4
Permax side effect was reported by a Consumer or non-health professional from JAPAN on Feb 04, 2008. Female patient, 81 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: eosinophilic pneumonia acute, interstitial lung disease, lymphocyte stimulation test positive, pleural calcification, pleural effusion, pneumocystis jiroveci pneumonia, pneumonia cytomegaloviral, pneumonia primary atypical, pneumonitis. Permax dosage: unknown. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, AMANTADINE, CLONAZEPAM, LEVODOPA BENSERAZIDE HYDROCHLO, LEVODOPA BENSERAZIDE HYDROCHLO. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #4648434-4
Permax side effect was reported by a Physician from on Apr 08, 2005. Male patient, 75 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: chest pain , chest wall mass, haemothorax, pleural effusion, pleurisy, pneumonia aspiration. Permax dosage: unknown. Patient died on 06/01/2004.

Permax Side Effects Report #5584487-7
Permax side effect was reported by a Physician from JAPAN on Apr 19, 2007. Male patient, 73 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: aphagia, pericardial effusion, pericarditis, pleural effusion. Permax dosage: unknown. During the same period patient was treated with MENESIT, PARMIPEXOLE, PROSTAL, HARNAL, MAGNESIUM OXIDE, MUCODYNE, MUCOSAL, AMBROXOL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #4983748-X
Permax side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 02, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: parkinsonism, pleural effusion, pulmonary fibrosis . Permax dosage: 1.5 MG;QD. During the same period patient was treated with BROMOCRIPTINE MESYLATE, AMANTADINE, LEVODOPA, CARBIDOPA, LISINOPRIL, SPIRONOLACTONE, FUROSEMIDE, ACETYLSALICYLIC ACID SRT. Patient recovered.


Permax Side Effects Report #5036215-1
Permax side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 02, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: parkinsonism, pleural effusion, pulmonary fibrosis . Permax dosage: 1.5 MG;QD. During the same period patient was treated with BROMOCRIPTINE MESYLATE, AMANTADINE, LEVODOPA, CARBIDOPA, LISINOPRIL, SPIRONOLACTONE, FUROSEMIDE, ACETYLSALICYLIC ACID SRT. Patient recovered.

Permax Side Effects Report #5386011-0
Permax side effect was reported by a Health Professional from JAPAN on July 03, 2007. Male patient was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, platelet count decreased, pleural effusion, pleurisy, pulmonary alveolar haemorrhage, systemic lupus erythematosus. Permax dosage: unknown. Patient recovered.

Permax Side Effects Report #5397254-4
Permax side effect was reported by a Health Professional from JAPAN on July 16, 2007. Male patient was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, pleural effusion, pleurisy, pulmonary alveolar haemorrhage, systemic lupus erythematosus. Permax dosage: unknown. Patient recovered.

Permax Side Effects Report #5404725-0
Permax side effect was reported by a Health Professional from JAPAN on July 26, 2007. Male patient was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, lupus-like syndrome, platelet count decreased, pleural effusion, pleurisy, pulmonary alveolar haemorrhage. Permax dosage: unknown. During the same period patient was treated with SYMMETREL, MADOPAR. Patient was hospitalized. Patient recovered.

Permax Side Effects Report #5526190-5
Permax side effect was reported by a Physician from GERMANY on Nov 02, 2007. Male patient was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: amyloidosis, anaemia, atelectasis, depression , gamma-glutamyltransferase increased, pericarditis constrictive, pleural effusion, pleural fibrosis, pneumonia . Permax dosage: 1 MG;QID;PO. During the same period patient was treated with LEVODOPA, CLOZAPINE, DIOVAN HCT, CARBIDOPA, COMTESS, FUROSEMIDE. Patient was hospitalized. Patient recovered.


Permax Side Effects Report #5584484-1
Permax side effect was reported by a Health Professional from JAPAN on Feb 09, 2007. Female patient was diagnosed with parkinson's disease  and was treated with Permax. After drug was administered, patient experienced the following side effects: pleural effusion, tuberculosis . Permax dosage: unknown. Patient was hospitalized. Patient recovered.